1 Also applies to receipt of PCV7 at any age and no other pneumococcal vaccines. 2 For those with an immunocompromising condition, cochlear implant, or CSF leak, consider a minimum interval of ...

A research team has evaluated the real-world impact of a community-based pneumococcal vaccination support program for older ...

Family Physician, talks about the importance of adult vaccination, including the pneumococcal pneumonia vaccine.

There are several additional pneumococcal vaccines for adults and children in clinical development. Pn-MAPS24V is a novel 24-valent pneumococcal vaccine that contains the 13 serotypes in PCV13, an ...

The advisors also voted 14-1 to recommend a pneumococcal conjugate vaccine (PCV) for all PCV-naive adults ages 50 and older. Shortly after the ACIP meeting, CDC Director Mandy Cohen, MD, MPH ...

This age barrier may change soon. On Wednesday, a panel with the Centers for Disease Control and Prevention voted to lower the recommended age for older adults to get their first pneumococcal vaccine.

If you're at least 50, here's which vaccines you're eligible for this fall and winter season. Pneumococcal vaccine: Age 50 and up Pneumonia is an infection in the lungs that can be caused by a ...

"Lowering the age for pneumococcal vaccination gives more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infection substantially increases," the ...

CAPVAXIVE is Merck's approved 21-valent pneumococcal conjugate vaccine indicated for active immunization for the prevention of invasive disease and pneumonia in adults 18 years of age and older.

US CDC Recommends Expanding Pneumococcal Vaccines to Adults Aged 50-64 (Reuters) -The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to ...

Pneumococcal vaccine The pneumococcus (pneumonia) vaccine is recommended for children younger than 5 years and adults 50 years or older. This is an update to previous guidance, which called for ...

A research team has evaluated the real-world impact of a community-based pneumococcal vaccination support program for older adults conducted in Sera ...